Meroni PL - Search Results

1

Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?

Favalli EG, Biggioggero M, Meroni PL. Favalli EG, et al. Among authors: meroni pl. Autoimmun Rev. 2014 Nov;13(11):1102-8. doi: 10.1016/j.autrev.2014.08.026. Epub 2014 Aug 26. Autoimmun Rev. 2014. PMID: 25172238 Review.

2

Enhanced percentage of Leu M3+DR+ and Leu M3+CD25+ cells in newly diagnosed IDDM patients.

Nicoletti F, Consoli U, Calogero D, Speciale AM, Di Marco R, Leonardi C, La Rosa L, Lunetta M, Di Cataldo A, Meroni PL. Nicoletti F, et al. Among authors: meroni pl. Autoimmunity. 1991;9(3):255-9. doi: 10.3109/08916939109007651. Autoimmunity. 1991. PMID: 1777558

3

Fusidic acid and insulin-dependent diabetes mellitus.

Nicoletti F, Meroni PL, Bendtzen K. Nicoletti F, et al. Among authors: meroni pl. Autoimmunity. 1996;24(3):187-97. doi: 10.3109/08916939608995364. Autoimmunity. 1996. PMID: 9020411 Review.

4

Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.

Xiang M, Zaccone P, Di Marco R, Harris R, Magro G, Di Mauro M, Meroni PL, Garotta G, Nicoletti F. Xiang M, et al. Among authors: meroni pl. Autoimmunity. 1999;30(2):71-80. doi: 10.3109/08916939908994763. Autoimmunity. 1999. PMID: 10435719

5

Overview on anticardiolipin ELISA standardization.

Tincani A, Balestrieri G, Allegri F, Cinquini M, Vianelli M, Taglietti M, Sanmarco M, Ichikawa K, Koike T, Meroni P, Boffa MC. Tincani A, et al. J Autoimmun. 2000 Sep;15(2):195-7. doi: 10.1006/jaut.2000.0399. J Autoimmun. 2000. PMID: 10968908 Review. No abstract available.

6

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.

Meroni PL, Raschi E, Camera M, Testoni C, Nicoletti F, Tincani A, Khamashta MA, Balestrieri G, Tremoli E, Hess DC. Meroni PL, et al. J Autoimmun. 2000 Sep;15(2):237-40. doi: 10.1006/jaut.2000.0412. J Autoimmun. 2000. PMID: 10968917 Review. No abstract available.

7

The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells.

Nicoletti F, Di Marco R, Patti F, Nicoletti A, Leonardi C, Reggio E, Meroni P, Reggio A. Nicoletti F, et al. Autoimmunity. 2000 Dec;32(4):265-70. doi: 10.3109/08916930008994100. Autoimmunity. 2000. PMID: 11191285

8

Are cardiovascular diseases a subspeciality of clinical immunology?

Meroni PL, Riboldi P. Meroni PL, et al. Clin Rev Allergy Immunol. 2002 Dec;23(3):243-5. doi: 10.1385/CRIAI:23:3:243. Clin Rev Allergy Immunol. 2002. PMID: 12402410 No abstract available.

9

Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?

Meroni PL, Luzzana C, Ventura D. Meroni PL, et al. Clin Rev Allergy Immunol. 2002 Dec;23(3):263-77. doi: 10.1385/CRIAI:23:3:263. Clin Rev Allergy Immunol. 2002. PMID: 12402412 Review.

10

Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention.

Meroni PL, Raschi E, Testoni C. Meroni PL, et al. Autoimmun Rev. 2002 Feb;1(1-2):55-60. doi: 10.1016/s1568-9972(01)00014-3. Autoimmun Rev. 2002. PMID: 12849059 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results